Acute gastritis
Local effects such as drugs, alcohol, nicotine, irregular eating, bacterial toxins, infection by Helicobacter pylori, and stress resulting from trauma, burns, shock, and surgery often trigger inflammatory changes in the gastric mucosa by damaging the mucosal barrier
Nutritional recommendations in acute gastritis
As part of nutritional therapy, alcohol, nicotine, and drugs that damage the mucosa must be avoided in particular.
Chronic gastritis
Chronic gastritis is divided into three types:
Chronic gastritis type A Autoimmune gastritis 5% of cases.
This form of gastritis is an autoimmune disease with antibodies to the gastric mucosal cells or intrinsic factor, resulting in mucosal atrophy (regression of the mucosa) and a lack of hydrochloric acid in the stomach. On the one hand, folic acid can no longer be sufficiently absorbed, and on the other hand, the gastric mucosa is no longer able to produce sufficient amounts of the intrinsic factor required for vitamin B12 absorption. The symptoms that occur are usually the result of a vitamin B12 deficiency. Affected individuals must be injected intramuscularly with vitamin B12 for the rest of their lives. Chronic gastritis type B 85 % of cases
The type B form of chronic gastritis is triggered in about 90% of cases by a colonization of the gastric mucosa with the bacterium Helicobacter pylori. In most cases, mucosal colonization with these pathogens occurs as a result of inadequate housing, food and drinking water hygiene. An excessively high salt content in the diet in cured and smoked foods as well as increased caffeine and alcohol consumption also promote a Helicobacter pylori infection. Both the ammonia produced by the pathogen and specific cytotoxins (cell toxins) damage the mucosa, resulting in tissue loss of the mucosa and reduced gastric acid secretion. Consequently, the pH of gastric juice increases, causing bacterial colonization of the normally largely sterile stomach. The increased bacterial count in gastric juice also favors the development of gastric cancer, as nitrate-reducing bacteria convert the ingested nitrate into nitrite. Nitrite and nitrogenous substances can form cancer-causing N-nitrose compounds in the stomach. If attention is paid to an adequate intake of secondary plant compounds, such as phenolic acids, flavonoids and sulfides, the growth of cancer cells in esophageal, gastric and colon cancer can be inhibited. Sulfides specifically protect against stomach cancer. Adequate dietary sulfide intake can inhibit bacterial growth in the stomach due to its antibacterial effect. As a result, less nitrate is converted into nitrite and consequently fewer cancer-promoting nitrosamines are formed. Phenolic acids also exhibit protective effects against stomach cancer. They have a strong antioxidant effect and can thus inactivate numerous cancer-promoting substances, especially nitrosamines and mycotoxins [4.3]. Secondary plant compounds are also able to inhibit the phase 1 enzymes responsible for carcinogenesis and prevent the growth of DNA-damaged cells. In addition, they activate natural killer cells as well as cell-killing T-lymphocytes to stop carcinogenesis. The absorption (uptake) of some vital substances is significantly impaired both by the infection with Helicobacter pylori itself and by the widespread therapy with various combined antibiotics and proton pump inhibitors inhibit the occupant cells and thus the acid production. Intestinal absorption of vitamins B12, C, E, beta-carotene and iron may thus be reduced. Chronic gastritis type C 10% of cases.
The type C form is a chemically triggered gastritis and results from the reflux of bile from the duodenum.
Chronic gastritis vital substance deficiency
Vital substance | Deficiency symptoms |
Beta-carotene |
|
Vitamin E |
Deficiency symptoms in children
|
Vitamin B12 |
Blood picture pernicious anemia
Gastrointestinal tract
Neurological disorders
Psychiatric disorders
|
Vitamin C |
Weakness of blood vessels leads to
Carnitine deficit leads to
Deficiency symptoms in children
Increased risk of vitamin C deficiency disease Möller-Barlow disease in infancy with symptoms such as.
|
Iron |
Symptoms of deficiency in children
|